(Q46428265)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Olga Volpert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Juan Miguel Redondo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Quesada AJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Nelius T

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Yap R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Zaichuk TA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Alfranca A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

649-658

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

The cell biology of thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Fas (CD95)- and tumor necrosis factor-mediated apoptosis in liver endothelial cells: role of caspase-3 and the p38 MAPK

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

CD95(APO-1/Fas)-mediated apoptosis: live and let die

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Cellular stress response and apoptosis in cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Doxorubicin-induced apoptosis: implications in cardiotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Doxorubicin and multidrug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Doxorubicin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Mechanistic insights on the inhibition of tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

A checkerboard method to evaluate interactions between drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

The functions of thrombospondin-1 and-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Inhibition of angiogenesis by thrombospondin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

The CD95(APO-1/Fas) DISC and beyond

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Mechanisms of p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

p53 and apoptosis: it's not just in the nucleus anymore

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

p53 has a direct apoptogenic role at the mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

PUMA, a novel proapoptotic gene, is induced by p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Signaling through CD31 protects endothelial cells from apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

The biology of PECAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Oxidized LDL activates fas-mediated endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Fas ligation triggers apoptosis in macrophages but not endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Angiogenesis and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Is HIF-1alpha a pro- or an anti-apoptotic protein?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Human dermal microvascular endothelial cells: an improved method for tissue culture and a description of some singular properties in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401615

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15818399%20AND%20SRC:MED&resulttype=core&format=json

release_ylsnimghnve4xpy2o4xqcdgzii

10 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ylsnimghnve4xpy2o4xqcdgzii

24 November 2022

mapped directly with Wikidata item

1 reference